The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis.

Journal: Prostate international
Published Date: Nov 4, 2021

Abstract

OBJECTIVES: To evaluate the detection rate of clinically significant prostate cancer (csPCa) in Magnetic resonance imaging and ultrasonography (MRI/US) fusion biopsy in patients with biopsy-naïve men for varying prostate-specific antigen (PSA) levels. Since MRI can efficiently detect csPCa compared to standard transrectal ultrasound (TRUS) guided biopsy; however, the optimal PSA threshold for its use is unclear.

Authors

  • Hye J Byun
    Department of Urology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.
  • Teak J Shin
    Department of Urology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.
  • Wonho Jung
    Department of Urology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.
  • Ji Y Ha
    Department of Urology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.
  • Byung H Kim
    Department of Urology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.
  • Young H Kim
    Department of Radiology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, South Korea.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals